JAC Advance Access originally published online on April 14, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 51, 1167-1173
© 2003 The British Society for Antimicrobial Chemotherapy
Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus
Unité de Pharmacologie Cellulaire et Moléculaire, Université Catholique de Louvain, UCL 73.70 Avenue E. Mounier 73, B-1200 Brussels, Belgium
Received 20 January 2003; returned 3 February 2003; revised 8 February 2003; accepted 20 February 2003
Antibiotic efflux pumps expressed in eukaryotic cells can decrease the intracellular accumulation of the corresponding drugs and therefore impair their activity against intracellular bacteria. We have investigated whether verapamil (an inhibitor of P-glycoprotein) and gemfibrozil (an inhibitor of multidrug resistance proteins (MRP) and other organic anion transporters), can modulate the intracellular activity of azithromycin and ciprofloxacin against Listeria monocytogenes and Staphylococcus aureus in J774 macrophages. In parallel, we have measured the cell accumulation and subcellular distribution of both drugs. Antibiotics were used at equipotent extracellular concentrations (from 0.5 x to 10 x MIC) to allow for pharmacological comparisons. Azithromycin was bacteriostatic against L. monocytogenes and slightly bactericidal against S. aureus. Verapamil did not improve the maximal activity of azithromycin but allowed it to reach a similar effect at extracellular concentrations about seven-fold lower in both models. Azithromycin was predominantly localized in cell granules (66%), the remainder being in the cytosol and in the ‘nuclei/unbroken cells’ fraction. Verapamil increased the cellular accumulation of azithromycin by almost 2.4-fold without modifying its subcellular distribution. Ciprofloxacin displayed a strong concentration-dependent bactericidal activity in both models. Gemfibrozil increased ciprofloxacin activity almost 2.5-fold against L. monocytogenes, but not against S. aureus. Ciprofloxacin was predominantly (65%) distributed in the cytosol. Gemfibrozil increased ciprofloxacin total accumulation by 
2.4-fold, but the excess was only found in the cytosol. Inhibition of efflux pumps may be a useful strategy to improve antibiotic efficacy against intracellular bacteria when increased accumulation can be obtained in the compartment where bacteria sojourn.
Keywords: transporters, intracellular, accumulation, verapamil, gemfibrozil
* Corresponding author. Tel: +32-2-764-7356; Fax: +32-2-764-7373; E-mail: tulkens{at}facm.ucl.ac.be
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Van de Velde, H. A. Nguyen, F. Van Bambeke, P. M. Tulkens, J. Grellet, V. Dubois, C. Quentin, and M.-C. Saux Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes J. Antimicrob. Chemother., September 1, 2008; 62(3): 518 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lismond, P. M. Tulkens, M.-P. Mingeot-Leclercq, P. Courvalin, and F. Van Bambeke Cooperation between Prokaryotic (Lde) and Eukaryotic (MRP) Efflux Transporters in J774 Macrophages Infected with Listeria monocytogenes: Studies with Ciprofloxacin and Moxifloxacin Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3040 - 3046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lemaire, F. Van Bambeke, M.-P. Mingeot-Leclercq, and P. M. Tulkens Modulation of the Cellular Accumulation and Intracellular Activity of Daptomycin towards Phagocytized Staphylococcus aureus by the P-Glycoprotein (MDR1) Efflux Transporter in Human THP-1 Macrophages and Madin-Darby Canine Kidney Cells Antimicrob. Agents Chemother., August 1, 2007; 51(8): 2748 - 2757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Nguyen, J. Grellet, V. Dubois, M.-C. Saux, and C. Quentin Factors compromising the activity of moxifloxacin against intracellular Staphylococcus aureus J. Antimicrob. Chemother., April 1, 2007; 59(4): 755 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Shandil, R. Jayaram, P. Kaur, S. Gaonkar, B. L. Suresh, B. N. Mahesh, R. Jayashree, V. Nandi, S. Bharath, and V. Balasubramanian Moxifloxacin, Ofloxacin, Sparfloxacin, and Ciprofloxacin against Mycobacterium tuberculosis: Evaluation of In Vitro and Pharmacodynamic Indices That Best Predict In Vivo Efficacy Antimicrob. Agents Chemother., February 1, 2007; 51(2): 576 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Michot, M. F. Heremans, N. E. Caceres, M.-P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke Cellular accumulation and activity of quinolones in ciprofloxacin-resistant j774 macrophages. Antimicrob. Agents Chemother., May 1, 2006; 50(5): 1689 - 1695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Nguyen, J. Grellet, D. Paillard, V. Dubois, C. Quentin, and M.-C. Saux Factors influencing the intracellular activity of fluoroquinolones: a study using levofloxacin in a Staphylococcus aureus THP-1 monocyte model J. Antimicrob. Chemother., May 1, 2006; 57(5): 883 - 890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Langer, R. Karch, U. Muller, G. Dobrozemsky, A. Abrahim, M. Zeitlinger, E. Lackner, C. Joukhadar, R. Dudczak, K. Kletter, et al. Combined PET and Microdialysis for In Vivo Assessment of Intracellular Drug Pharmacokinetics in Humans J. Nucl. Med., November 1, 2005; 46(11): 1835 - 1841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Michot, C. Seral, F. Van Bambeke, M.-P. Mingeot-Leclercq, and P. M. Tulkens Influence of Efflux Transporters on the Accumulation and Efflux of Four Quinolones (Ciprofloxacin, Levofloxacin, Garenoxacin, and Moxifloxacin) in J774 Macrophages Antimicrob. Agents Chemother., June 1, 2005; 49(6): 2429 - 2437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Seral, M. Barcia-Macay, M. P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages J. Antimicrob. Chemother., April 1, 2005; 55(4): 511 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Van Bambeke, S. Carryn, C. Seral, H. Chanteux, D. Tyteca, M.-P. Mingeot-Leclercq, and P. M. Tulkens Cellular Pharmacokinetics and Pharmacodynamics of the Glycopeptide Antibiotic Oritavancin (LY333328) in a Model of J774 Mouse Macrophages Antimicrob. Agents Chemother., August 1, 2004; 48(8): 2853 - 2860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Michot, F. Van Bambeke, M.-P. Mingeot-Leclercq, and P. M. Tulkens Active Efflux of Ciprofloxacin from J774 Macrophages through an MRP-Like Transporter Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2673 - 2682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. A. Qazi, S. E. Harrison, T. Self, P. Williams, and P. J. Hill Real-Time Monitoring of Intracellular Staphylococcus aureus Replication J. Bacteriol., February 15, 2004; 186(4): 1065 - 1077. [Abstract] [Full Text] [PDF]
|
|